Share on LinkedInShare on LinkedIn

ARTICLE · 02 SEPTEMBER 2014

Weeks II: Innovator Liability Finds A Sweet Home In Alabama

Morrison Foerster
Morrison Foerster
Contributor
Morrison Foerster

Morrison Foerster

With approximately 1,000 lawyers in 19 offices, Morrison & Foerster is a preeminent global law firm...

View firm profile
Explore more from Morrison Foerster

Last week, the Supreme Court of Alabama confirmed its January 2013 holding that manufacturers of brand drugs can be liable for injuries caused by generic drugs.

United StatesLitigation, Mediation & Arbitration

Last week, the Supreme Court of Alabama confirmed its January 2013 holding that manufacturers of brand drugs can be liable for injuries caused by generic drugs. Weeks v. Wyeth, Inc., No. 1101397, slip op. (Ala. Aug. 15, 2014). Though the recent ruling puts Alabama in a very small minority of jurisdictions recognizing "innovator liability," it still represents a state supreme court holding that exposes brand drug manufacturers to liability they had not previously known. The ruling will likely result in significant new filings by the plaintiffs' bar in Alabama, and renewed arguments by them for other jurisdictions to follow Alabama's reasoning.

REARGUMENT AFTER JANUARY 2013 OPINION

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from